These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18692530)

  • 1. Effect of hepatocyte growth factor encapsulated in targeted liposomes on liver cirrhosis.
    Li F; Sun JY; Wang JY; Du SL; Lu WY; Liu M; Xie C; Shi JY
    J Control Release; 2008 Oct; 131(1):77-82. PubMed ID: 18692530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats.
    Du SL; Pan H; Lu WY; Wang J; Wu J; Wang JY
    J Pharmacol Exp Ther; 2007 Aug; 322(2):560-8. PubMed ID: 17510318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antifibrotic effects of cyclic RGD-peptide mediated liposomal interferon: an experimental on rats].
    Du SL; Wang JY; Pan H; Lu WY; Wang J
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1015-20. PubMed ID: 16029541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
    Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY
    J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of HGF carried by ultrasound microbubble-cationic nano-liposomes complex for treating hepatic fibrosis in a bile duct ligation rat model, and its relationship with the diffusion-weighted MRI parameters.
    Zhang SH; Wen KM; Wu W; Li WY; Zhao JN
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):602-7. PubMed ID: 24012221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor.
    Oe S; Fukunaka Y; Hirose T; Yamaoka Y; Tabata Y
    J Control Release; 2003 Mar; 88(2):193-200. PubMed ID: 12628327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis.
    Matsuda Y; Matsumoto K; Yamada A; Ichida T; Asakura H; Komoriya Y; Nishiyama E; Nakamura T
    Hepatology; 1997 Jul; 26(1):81-9. PubMed ID: 9214455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted treatment of choroidal neovascularization using integrin-mediated sterically stabilized liposomes loaded with combretastatin A4.
    Ma L; Liu YL; Ma ZZ; Dou HL; Xu JH; Wang JC; Zhang X; Zhang Q
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):195-200. PubMed ID: 19456253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.
    Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
    J Pharm Sci; 2005 Aug; 94(8):1782-93. PubMed ID: 15986461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats.
    Kusumoto K; Ido A; Moriuchi A; Katsura T; Kim I; Takahama Y; Numata M; Kodama M; Hasuike S; Nagata K; Uto H; Inui K; Tsubouchi H
    Int J Mol Med; 2006 Mar; 17(3):503-9. PubMed ID: 16465399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies.
    Xie Y; Ye L; Zhang X; Cui W; Lou J; Nagai T; Hou X
    J Control Release; 2005 Jun; 105(1-2):106-19. PubMed ID: 15893839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Circulating Liposomal Delivery System Targeting at PDGFR-β Enhances the Therapeutic Effect of IFN-α on Hepatic Fibrosis.
    Li Q; Yu Q; Ju J; You T; Yan Z; Nan X; Zhong J; Zhou JE
    Curr Pharm Des; 2017; 23(20):3034-3046. PubMed ID: 27928957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.
    Kim WH; Matsumoto K; Bessho K; Nakamura T
    Am J Pathol; 2005 Apr; 166(4):1017-28. PubMed ID: 15793283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells.
    Chen CW; Lu DW; Yeh MK; Shiau CY; Chiang CH
    Int J Nanomedicine; 2011; 6():2567-80. PubMed ID: 22128247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
    Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X
    Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The improving effects on hepatic fibrosis of interferon-γ liposomes targeted to hepatic stellate cells.
    Li Q; Yan Z; Li F; Lu W; Wang J; Guo C
    Nanotechnology; 2012 Jul; 23(26):265101. PubMed ID: 22700686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disaccharide-modified liposomes and their in vitro intracellular uptake.
    Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H
    Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic.
    Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
    J Control Release; 2005 Oct; 107(2):262-75. PubMed ID: 16125816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
    Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
    J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.